{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:53:37Z","timestamp":1744206817949,"version":"3.32.0"},"reference-count":22,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2024]]},"DOI":"10.1620\/tjem.2024.j059","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T22:12:59Z","timestamp":1720044779000},"page":"159-167","source":"Crossref","is-referenced-by-count":1,"title":["Tumor Forkhead Box J2 as a Biomarker Reflecting Risks of Recurrence and Death in Non-Small Cell Lung Cancer Receiving Surgical Resection"],"prefix":"10.1620","volume":"264","author":[{"given":"Riya","family":"Su","sequence":"first","affiliation":[{"name":"Department of Oncology, Inner Mongolia Medicine University Affiliated Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Inner Mongolia Medicine University Affiliated Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Oncology, Inner Mongolia Medicine University Affiliated Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Oncology, Inner Mongolia Medicine University Affiliated Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rihan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Inner Mongolia Medicine University Affiliated Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Inner Mongolia Medicine University Affiliated Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Alduais, Y., Zhang, H., Fan, F., Chen, J. &amp; Chen, B. (2023)  Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment.  <i>Medicine<\/i> (<i>Baltimore<\/i>), 102, e32899.","DOI":"10.1097\/MD.0000000000032899"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Alexander, M., Kim, S.Y. &amp; Cheng, H. (2020)  Update 2020: Management of Non-Small Cell Lung Cancer.  <i>Lung<\/i>, 198, 897-907.","DOI":"10.1007\/s00408-020-00407-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Chaft, J.E., Rimner, A., Weder, W., Azzoli, C.G., Kris, M.G. &amp; Cascone, T. (2021)  Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer.  <i>Nat. Rev. Clin. Oncol.<\/i>, 18, 547-557.","DOI":"10.1038\/s41571-021-00501-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chen, P., Liu, Y., Wen, Y. &amp; Zhou, C. (2022)  Non-small cell lung cancer in China.  <i>Cancer Commun.<\/i> (<i>Lond<\/i>), 42, 937-970.","DOI":"10.1002\/cac2.12359"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Cruz, C., Afonso, M., Oliveiros, B. &amp; Pego, A. (2017)  Recurrence and Risk Factors for Relapse in Patients with Non-Small Cell Lung Cancer Treated by Surgery with Curative Intent.  <i>Oncology<\/i>, 92, 347-352.","DOI":"10.1159\/000458533"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Ettinger, D.S., Wood, D.E., Aisner, D.L., Akerley, W., Bauman, J.R., Bharat, A., Bruno, D.S., Chang, J.Y., Chirieac, L.R., D\u2019Amico, T.A., DeCamp, M., Dilling, T.J., Dowell, J., Gettinger, S., Grotz, T.E., et al.  (2022)  Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.  <i>J. Natl. Compr. Canc. Netw.<\/i>, 20, 497-530.","DOI":"10.6004\/jnccn.2022.0025"},{"key":"7","unstructured":"Guo, G. &amp; Zhu, L. (2022)  FOXJ2 Inhibits the Proliferation, Migration and Epithelial-Mesenchymal Transition of Prostate Carcinoma Cells.  <i>Ann. Clin. Lab. Sci.<\/i>, 52, 731-740."},{"key":"8","doi-asserted-by":"crossref","unstructured":"Jin, G.Z., Zhang, Y., Cong, W.M., Wu, X., Wang, X., Wu, S., Wang, S., Zhou, W., Yuan, S., Gao, H., Yu, G. &amp; Yang, W. (2018)  Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking.  <i>PLoS Biol.<\/i>, 16, e2006483.","DOI":"10.1371\/journal.pbio.2006483"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Jin, Y., Liang, Z. &amp; Lou, H. (2020)  The Emerging Roles of Fox Family Transcription Factors in Chromosome Replication, Organization, and Genome Stability.  <i>Cells<\/i>, 9, 258.","DOI":"10.3390\/cells9010258"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Li, Y., Zhu, X., Liu, C., Han, Q., Chen, X., Liu, Y., Yin, Y., He, A. &amp; Xia, F. (2021)  Low FOXJ2 expression is associated with unfavorable postoperative prognosis of patients with epithelial ovarian cancer.  <i>Medicine<\/i> (<i>Baltimore<\/i>), 100, e24759.","DOI":"10.1097\/MD.0000000000024759"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Martin-de-Lara, F., Sanchez-Aparicio, P., Arias de la Fuente, C. &amp; Rey-Campos, J. (2008)  Biological effects of FoxJ2 over-expression.  <i>Transgenic Res.<\/i>, 17, 1131-1141.","DOI":"10.1007\/s11248-008-9214-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Nicholson, A.G., Tsao, M.S., Beasley, M.B., Borczuk, A.C., Brambilla, E., Cooper, W.A., Dacic, S., Jain, D., Kerr, K.M., Lantuejoul, S., Noguchi, M., Papotti, M., Rekhtman, N., Scagliotti, G., van Schil, P., et al.  (2022)  The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.  <i>J. Thorac. Oncol.<\/i>, 17, 362-387.","DOI":"10.1016\/j.jtho.2021.11.003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Qiang, Y., Feng, L., Wang, G., Liu, J., Zhang, J., Xiang, L., Su, C., Zhang, S., Xie, X. &amp; Chen, E. (2020)  miR-20a\/Foxj2 Axis Mediates Growth and Metastasis of Colorectal Cancer Cells as Identified by Integrated Analysis.  <i>Med. Sci. Monit.<\/i>, 26, e923559.","DOI":"10.12659\/MSM.923559"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Qiang, Y., Wang, F., Yan, S., Zhang, H., Zhu, L., Chen, Z., Tu, F., Wang, D., Wang, G., Wang, W. &amp; Chen, Z. (2015)  Abnormal expression of Forkhead Box J2 (FOXJ2)  suppresses migration and invasion in extrahepatic cholangiocarcinoma and is associated with prognosis.  <i>Int. J. Oncol.<\/i>, 46, 2449-2458.","DOI":"10.3892\/ijo.2015.2957"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Shan, Y., Chang, T., Shi, S., Tang, M., Bao, L., Li, L., You, B. &amp; You, Y. (2017)  Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma.  <i>Onco Targets Ther.<\/i>, 10, 3733-3741.","DOI":"10.2147\/OTT.S134915"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Tang, Y., Qiao, G., Xu, E., Xuan, Y., Liao, M. &amp; Yin, G. (2017)  Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer.  <i>Onco Targets Ther.<\/i>, 10, 4527-4534.","DOI":"10.2147\/OTT.S142149"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Torrente, M., Sousa, P.A., Franco, F., Guerreiro, G., Sousa, A., Parejo, C., Pimentao, J. &amp; Provencio, M. (2022)  Understanding prognosis and survival outcomes in patients with early-stage non-small-cell lung cancer.  <i>Clin. Med.<\/i> (<i>Lond<\/i>), 22, 38-40.","DOI":"10.7861\/clinmed.22-4-s38"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Travis, W.D., Brambilla, E., Nicholson, A.G., Yatabe, Y., Austin, J.H.M., Beasley, M.B., Chirieac, L.R., Dacic, S., Duhig, E., Flieder, D.B., Geisinger, K., Hirsch, F.R., Ishikawa, Y., Kerr, K.M., Noguchi, M., et al.  (2015)  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.  <i>J. Thorac. Oncol.<\/i>, 10, 1243-1260.","DOI":"10.1097\/JTO.0000000000000630"},{"key":"19","unstructured":"Uramoto, H. &amp; Tanaka, F. (2014)  Recurrence after surgery in patients with NSCLC.  <i>Transl. Lung Cancer Res.<\/i>, 3, 242-249."},{"key":"20","doi-asserted-by":"crossref","unstructured":"Yang, Q., Cao, X., Tao, G., Zhou, F., Zhao, P., Shen, Y. &amp; Chen, X. (2017)  Effects of FOXJ2 on TGF-beta1-induced epithelial-mesenchymal transition through Notch signaling pathway in non-small lung cancer.  <i>Cell Biol. Int.<\/i>, 41, 79-83.","DOI":"10.1002\/cbin.10680"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Meng, G., Wang, L., Ma, Y. &amp; Guan, Z. (2016)  The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma.  <i>Mol. Med. Rep.<\/i>, 14, 254-262.","DOI":"10.3892\/mmr.2016.5261"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Zheng, Z., Zhang, X., Bai, J., Long, L., Liu, D. &amp; Zhou, Y. (2022)  PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K\/AKT pathway.  <i>Cancer Cell Int.<\/i>, 22, 201.","DOI":"10.1186\/s12935-022-02545-7"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/264\/4\/264_2024.J059\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T03:43:35Z","timestamp":1736567015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/264\/4\/264_2024.J059\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2024.j059","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"type":"print","value":"0040-8727"},{"type":"electronic","value":"1349-3329"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"2024.J059"}}